Abstract

88 Long-Term Responders to first-line single agent immunotherapy in advanced Non-Small Cell Lung Cancer. Real-world evidence from The Christie.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call